| Primary Bioscience, Inc. | Development of an ultra-low concentration biosensor for use in protein sequencing | Award starts Oct 1, 2026 | $939,084 | STTR Phase II | Federal award record |
| Conexeu Sciences Inc. (funding history) | | Filed Sep 29, 2026 | $30,875 | | SEC Form D |
| Hawkhill Therapeutics Ltd | | Filed Sep 29, 2026 | | | SEC Form D |
| Evia Bio, Inc. | | Filed Sep 28, 2026 | $5.5M | | SEC Form D |
| Argonaute RNA Ltd | | Filed Sep 24, 2026 | $1.8M | | SEC Form D |
| Seraxis Holdings, Inc. | | Filed Sep 24, 2026 | $10M | | SEC Form D |
| Swift Cardiovascular, Inc. | | Filed Sep 24, 2026 | $810,000 | | SEC Form D |
| Biophytis SA (funding history) | | Filed Sep 23, 2026 | $2.6M | | SEC Form D |
| Caspian Therapeutics, Inc. | | Filed Sep 23, 2026 | $50M | | SEC Form D |
| Digital Ether Computing, LLC (funding history) | | Filed Sep 23, 2026 | | | SEC Form D |
| Endless Corp (funding history) | | Filed Sep 23, 2026 | | | SEC Form D |
| Hera Biotech, Inc. (funding history) | | Filed Sep 23, 2026 | | | SEC Form D |
| Uvantis Therapeutics, Inc. | | Filed Sep 23, 2026 | $100,000 | | SEC Form D |
| Opus Medical Therapies, LLC | | Filed Sep 22, 2026 | $485,089 | | SEC Form D |
| Pierrepont Therapeutics, Inc. (funding history) | | Filed Sep 22, 2026 | | | SEC Form D |
| 3Helix, Inc. (funding history) | | Filed Sep 21, 2026 | $7.8M | | SEC Form D |
| Avery Therapeutics, Inc. | | Filed Sep 21, 2026 | $8.5M | | SEC Form D |
| Functional Longevity Labs, Inc. | | Filed Sep 21, 2026 | $25,000 | | SEC Form D |
| Jupiter Biomedical Research, Inc. (funding history) | | Filed Sep 21, 2026 | $30,000 | | SEC Form D |
| Lexaria Bioscience Corp. (funding history) | | Filed Sep 21, 2026 | $113,492 | | SEC Form D |
| Monocacy Therapeutics Inc. (funding history) | | Filed Sep 21, 2026 | $49 | | SEC Form D |
| Therapeutic Neuromodulation Systems LLC (funding history) | | Filed Sep 21, 2026 | $1.7M | | SEC Form D |
| Typewriter Therapeutics, Inc. | | Filed Sep 21, 2026 | $56.3M | | SEC Form D |
| Aqur Biosciences, Inc. | | Filed Sep 18, 2026 | $1.5M | | SEC Form D |
| Biotherapeutics, Inc. | Immunometabolic therapeutics for alzheimer's disease - immunometabolic therapeutics for alzheimer’s disease biotherapeutics inc (bti) is… | Award starts Sep 18, 2026 | $500,000 | SBIR Phase I | Federal award record |
| Cellfe, Inc | High throughput, high efficiency, rapid mechanical transfection for car t-cell therapeutics - project summary genetic modification of… | Award starts Sep 18, 2026 | $1.1M | SBIR Phase II | Federal award record |
| GevRx Nutraceuticals, Inc. | | Filed Sep 18, 2026 | $300,000 | | SEC Form D |
| Mabswitch Inc | Remote-controlled pc-car t-cell therapy for hard-to-treat solid tumors - project summary chimeric antigen receptor (car) t-cell… | Award starts Sep 18, 2026 | $399,998 | SBIR Phase II | Federal award record |
| Gliknik Inc (funding history) | | Filed Sep 17, 2026 | | | SEC Form D |
| IMACS Working Capital Facility One LLC | | Filed Sep 17, 2026 | $200,000 | | SEC Form D |
| Metabowlite, Inc. | | Filed Sep 17, 2026 | $50,000 | | SEC Form D |
| Pahtia Technologies Inc (funding history) | | Filed Sep 17, 2026 | $25,000 | | SEC Form D |
| SurgiBox Inc. (funding history) | | Filed Sep 17, 2026 | $486,000 | | SEC Form D |
| FibroBiologics, Inc. (funding history) | | Filed Sep 16, 2026 | $500,001 | | SEC Form D |
| Capienda Biotech, LLC | High-throughput kinetic system for small-molecule drug discovery - abstract evidence is accumulating for higher efficacy of small… | Award starts Sep 15, 2026 | $1.4M | SBIR Phase I | Federal award record |
| Hexamer Therapeutics, Inc (funding history) | | Filed Sep 15, 2026 | $500,000 | | SEC Form D |
| Vivacelle Bio Inc | Development of a phospholipid nanoparticle and small molecule-based combination drug for the treatment of lethal sepsis - project… | Award starts Sep 15, 2026 | $690,878 | SBIR Phase II | Federal award record |
| Harvard Apparatus Regenerative Technology, Inc. (funding history) | | Filed Sep 14, 2026 | $2.8M | | SEC Form D |
| Moonwalk Biosciences, Inc. (funding history) | | Filed Sep 14, 2026 | $60M | | SEC Form D |
| Amplica Bio, Inc. | | Filed Sep 11, 2026 | $30,000 | | SEC Form D |
| Retham Technologies, Inc. | | Filed Sep 11, 2026 | $1.1M | | SEC Form D |
| Tempo Therapeutics, Inc. (funding history) | | Filed Sep 11, 2026 | $14M | | SEC Form D |
| Can-Fite BioPharma Ltd. | | Filed Sep 10, 2026 | $8.3M | | SEC Form D |
| Polyrizon Ltd. (funding history) | | Filed Sep 10, 2026 | $4M | | SEC Form D |
| Praeventix, Inc. (funding history) | | Filed Sep 10, 2026 | | | SEC Form D |
| Quoin Pharmaceuticals Ltd. (funding history) | | Filed Sep 10, 2026 | $50M | | SEC Form D |
| Airway Therapeutics, Inc. | | Filed Sep 9, 2026 | $43.5M | | SEC Form D |
| BioLineRx Ltd. | | Filed Sep 9, 2026 | $3.8M | | SEC Form D |
| Cloverleaf Bio, Inc. | | Filed Sep 9, 2026 | $14.8M | | SEC Form D |
| Iambic Therapeutics, Inc. (funding history) | | Filed Sep 9, 2026 | $66M | | SEC Form D |
| Neosplice Therapeutics, Inc. | Isoform?resolved target discovery and validation in cancer - abstract neosplice therapeutics is developing an isoform-resolved target… | Award starts Sep 9, 2026 | $406,500 | SBIR Phase I | Federal award record |
| General Biophysics LLC | Xenon gas preservation of refrigerated platelets - abstract platelets are the primary coagulation blood component used for transfusion… | Award starts Sep 7, 2026 | $479,185 | SBIR Phase I | Federal award record |
| Keylicon Biosciences Inc | Improving the stability of sarna lnp formulations to overcome cold chain challenges - RNA vaccines have transformed the landscape of… | Award starts Sep 7, 2026 | $400,000 | SBIR Phase II | Federal award record |
| Sollus Therapeutics, Inc. | Enhancing antigen sensitivity of bcma car t cells for durable clinical responses inmultiple myeloma - project summary the prognosis for… | Award starts Sep 7, 2026 | $373,452 | STTR Phase I | Federal award record |
| Amygo Solutions LLC | Development of a blood-based diagnostic test for attr amyloidosis - project summary cardiac transthyretin amyloidosis (attr) is a… | Award starts Sep 5, 2026 | $329,469 | SBIR Phase I | Federal award record |
| Episteme Prognostics, Inc. (funding history) | | Filed Sep 4, 2026 | | | SEC Form D |
| Gossamer Bio, Inc. (funding history) | | Filed Sep 4, 2026 | $25M | | SEC Form D |
| Immunophotonics, Inc. (funding history) | | Filed Sep 4, 2026 | $10.1M | | SEC Form D |
| Pluri Inc. (funding history) | | Filed Sep 4, 2026 | $3.7M | | SEC Form D |
| Inventure, LLC (funding history) | | Filed Sep 3, 2026 | $82,345 | | SEC Form D |
| Superluminal Medicines, Inc. (funding history) | | Filed Sep 3, 2026 | $65.5M | | SEC Form D |
| Aclarity Genomics, Inc. | | Filed Sep 2, 2026 | $4.6M | | SEC Form D |
| Agen Genomics, Inc. | | Filed Sep 2, 2026 | $25,000 | | SEC Form D |
| Sensible Biotechnologies, Inc. (funding history) | | Filed Sep 2, 2026 | $13.5M | | SEC Form D |
| Telemachus Therapeutics, Inc. | | Filed Sep 2, 2026 | $125,000 | | SEC Form D |
| Cmtx Biotech Inc | A lung-specific, sulfonium lipid nanoparticle (slnp) formulation of incyclinide for the treatment of ali/ards - project summary/abstract… | Award starts Sep 1, 2026 | $367,988 | STTR Phase I | Federal award record |
| Everest Biolabs, Inc. | High-yield, high-purity extracellular vesicle isolation columns for high-throughput plate-based biomarker discovery and diagnosis -… | Award starts Sep 1, 2026 | $1.2M | SBIR Phase II | Federal award record |
| Halmos Labs | Maximum information per experiment, minimum experiments per conclusion | Fall 2026 | | Y Combinator batch | Y Combinator listing |
| MedeSol Global, Inc. | | Filed Sep 1, 2026 | $25,000 | | SEC Form D |
| Nxtcure Labs | The full-stack AI CRO for drug discovery. | Fall 2026 | | Y Combinator batch | Y Combinator listing |
| Rise Therapeutics LLC | A novel immunological-directed live biotherapy product for treating crohn's disease - project summary the goal of this project is to… | Award starts Sep 1, 2026 | $1M | SBIR Phase I | Federal award record |
| SuperRadiant | Embodied Scientific Intelligence | Fall 2026 | | Y Combinator batch | Y Combinator listing |
| Voxcell BioInnovation Inc. (funding history) | | Filed Sep 1, 2026 | $2.2M | | SEC Form D |
| Halia Therapeutics, Inc. (funding history) | | Filed Aug 31, 2026 | $3.5M | | SEC Form D |
| Plowshare Therapies LLC | | Filed Aug 31, 2026 | $6.7M | | SEC Form D |
| StrataBio Inc. | | Filed Aug 31, 2026 | $25,000 | | SEC Form D |
| Aegle Therapeutics Corp (funding history) | | Filed Aug 28, 2026 | $2.3M | | SEC Form D |
| Candor Therapeutics Inc. | | Filed Aug 28, 2026 | $50,000 | | SEC Form D |
| DalCor Pharmaceuticals US, LLC | | Filed Aug 28, 2026 | $7M | | SEC Form D |
| FluidForm Bio, Inc. | | Filed Aug 27, 2026 | $1.7M | | SEC Form D |
| Neopenda, PBC (funding history) | | Filed Aug 27, 2026 | $215,000 | | SEC Form D |
| Noveome Biotherapeutics, Inc. (funding history) | | Filed Aug 27, 2026 | $6.8M | | SEC Form D |
| Platform Therapeutics, Inc. | | Filed Aug 27, 2026 | $1.8M | | SEC Form D |
| Ubivac, Inc. (funding history) | | Filed Aug 27, 2026 | $80,000 | | SEC Form D |
| Aptevo Therapeutics Inc. (funding history) | | Filed Aug 26, 2026 | $3.5M | | SEC Form D |
| Auvi Labs, Inc. (funding history) | | Filed Aug 26, 2026 | $442,352 | | SEC Form D |
| Epicrispr Biotechnologies, Inc. | | Filed Aug 26, 2026 | $177M | | SEC Form D |
| ProEncia Biotechnology Inc. | | Filed Aug 26, 2026 | $1.5M | | SEC Form D |
| Turn Therapeutics Inc. | | Filed Aug 26, 2026 | $1.6M | | SEC Form D |
| XiltriX North America, LLC (funding history) | | Filed Aug 26, 2026 | $3M | | SEC Form D |
| MalarVx, Inc. | | Filed Aug 25, 2026 | $125,000 | | SEC Form D |
| OS Therapies Inc (funding history) | | Filed Aug 25, 2026 | $5M | | SEC Form D |
| AlloTRx Bio Inc. | | Filed Aug 24, 2026 | $500,000 | | SEC Form D |
| NewcelX Ltd. (funding history) | | Filed Aug 24, 2026 | $2.9M | | SEC Form D |
| Unravel Biosciences, Inc. (funding history) | | Filed Aug 24, 2026 | $4.1M | | SEC Form D |
| Citrachem Corp. | | Filed Aug 21, 2026 | $50,000 | | SEC Form D |
| NurExone Biologic Inc. (funding history) | | Filed Aug 21, 2026 | $450,456 | | SEC Form D |
| Amplifica Holdings Group, Inc. | | Filed Aug 20, 2026 | $25M | | SEC Form D |
| Dare Bioscience, Inc. (funding history) | | Filed Aug 20, 2026 | $12.4M | | SEC Form D |
| Ensysce Biosciences, Inc. (funding history) | | Filed Aug 20, 2026 | $77.2M | | SEC Form D |
| EXUMA Biotech Corp. | | Filed Aug 20, 2026 | $70M | | SEC Form D |
| Femasys Inc (funding history) | | Filed Aug 20, 2026 | $30M | | SEC Form D |
| LifeCyte Innovations, Inc. | | Filed Aug 20, 2026 | $1M | | SEC Form D |
| Sentonix, Inc. (funding history) | | Filed Aug 20, 2026 | $12.7M | | SEC Form D |
| Aer Therapeutics, Inc. (funding history) | | Filed Aug 19, 2026 | $3M | | SEC Form D |
| Apollomics Inc. | | Filed Aug 19, 2026 | $10M | | SEC Form D |
| Crescel LLC | | Filed Aug 19, 2026 | $1.1M | | SEC Form D |
| Guide Star Biosciences, Inc. | | Filed Aug 18, 2026 | $925,000 | | SEC Form D |
| InnovoTEX Inc. (funding history) | | Filed Aug 18, 2026 | $75,000 | | SEC Form D |
| EnduraFAST Inc. | | Filed Aug 17, 2026 | $50,000 | | SEC Form D |
| Georgiamune, Inc. | | Filed Aug 17, 2026 | $92.7M | | SEC Form D |
| Harton, Inc. | | Filed Aug 14, 2026 | $15.1M | | SEC Form D |
| Mbq Pharma Inc. (funding history) | | Filed Aug 14, 2026 | $1.5M | | SEC Form D |
| Strella Biotechnology, Inc. (funding history) | | Filed Aug 14, 2026 | $1.8M | | SEC Form D |
| Abcuro, Inc. (funding history) | | Filed Aug 13, 2026 | $39.4M | | SEC Form D |
| Aposture Surgical Corp | | Filed Aug 13, 2026 | $87,000 | | SEC Form D |
| Archean Sciences, Inc. | | Filed Aug 13, 2026 | $385,000 | | SEC Form D |
| Auron Therapeutics, Inc. (funding history) | | Filed Aug 13, 2026 | $7.1M | | SEC Form D |
| Khaya Biosciences, Inc. | | Filed Aug 13, 2026 | $200,000 | | SEC Form D |
| Simplicia, Inc. | | Filed Aug 13, 2026 | $600,000 | | SEC Form D |
| Entera Bio Ltd. (funding history) | | Filed Aug 12, 2026 | $275M | | SEC Form D |
| Paterna BioSciences HoldCo Inc. (funding history) | | Filed Aug 12, 2026 | $6.3M | | SEC Form D |
| Trace Biosciences Inc. | | Filed Aug 12, 2026 | $8.3M | | SEC Form D |
| Ella Leroy Corp | | Filed Aug 11, 2026 | $50,000 | | SEC Form D |
| Grace Therapeutics, Inc. (funding history) | | Filed Aug 11, 2026 | $10M | | SEC Form D |
| Merlin Biotech, Inc. | | Filed Aug 11, 2026 | $50,000 | | SEC Form D |
| ARC Medical Inc. (funding history) | | Filed Aug 10, 2026 | $117,668 | | SEC Form D |
| Bullseye Biodevices, Inc. | | Filed Aug 10, 2026 | $1.3M | | SEC Form D |
| InSitu Biologics, Inc. (funding history) | | Filed Aug 10, 2026 | $1.3M | | SEC Form D |
| Pleopharma, Inc. (funding history) | | Filed Aug 10, 2026 | $5.5M | | SEC Form D |
| Prana Therapies, Inc. (funding history) | | Filed Aug 10, 2026 | $40.2M | | SEC Form D |
| Automera US Inc. (funding history) | | Filed Aug 7, 2026 | $1M | | SEC Form D |
| BioGene Therapeutics Inc. (funding history) | | Filed Aug 7, 2026 | $3M | | SEC Form D |
| Claris Biotherapeutics, Inc. (funding history) | | Filed Aug 7, 2026 | $55.7M | | SEC Form D |
| Layka Bio Inc | | Filed Aug 7, 2026 | $300,000 | | SEC Form D |
| MedRhythms, Inc. (funding history) | | Filed Aug 7, 2026 | $1M | | SEC Form D |
| Shiverbright Technologies, Inc. | | Filed Aug 7, 2026 | $200,000 | | SEC Form D |
| Cerium Pharmaceuticals, Inc. | | Filed Aug 6, 2026 | $750,000 | | SEC Form D |
| HCW Biologics Inc. (funding history) | | Filed Aug 6, 2026 | $1.6M | | SEC Form D |
| Quicktake Health CO (funding history) | | Filed Aug 6, 2026 | $2.1M | | SEC Form D |
| Hepion Pharmaceuticals, Inc. (funding history) | | Filed Aug 5, 2026 | $3.1M | | SEC Form D |
| Integrated Biosciences, Inc. | | Filed Aug 5, 2026 | $68.4M | | SEC Form D |
| Jasper Therapeutics, Inc. | | Filed Aug 5, 2026 | $132M | | SEC Form D |
| Circinus Medical Technology LLC (funding history) | | Filed Aug 4, 2026 | $4.2M | | SEC Form D |
| Theradaptive, Inc. | | Filed Aug 4, 2026 | $36.2M | | SEC Form D |
| Monod Bio, Inc. | Design of rapid and quantitative biosensors with computational protein design - project summary monod bio’s fast-track proposal aims to… | Award starts Aug 1, 2026 | $377,260 | SBIR Phase I | Federal award record |
| Mangrove Therapeutics Inc. | | Filed Jul 31, 2026 | $2.5M | | SEC Form D |
| ORF Biologics, Inc. | | Filed Jul 31, 2026 | $1.7M | | SEC Form D |
| Oro Muscles, Inc. (funding history) | | Filed Jul 31, 2026 | $350,000 | | SEC Form D |
| PushCART Therapeutics, Inc. | | Filed Jul 31, 2026 | $500,000 | | SEC Form D |
| Ratio Therapeutics, Inc. (funding history) | | Filed Jul 31, 2026 | $70M | | SEC Form D |
| Genomenon, Inc. (funding history) | | Filed Jul 30, 2026 | $6M | | SEC Form D |
| NextPoint Therapeutics, Inc. (funding history) | | Filed Jul 30, 2026 | $33.7M | | SEC Form D |
| Born Science, LLC | | Filed Jul 29, 2026 | $250,000 | | SEC Form D |
| Magnendo Corp. (funding history) | | Filed Jul 29, 2026 | $18M | | SEC Form D |
| Research Discovery Innovation Inc. | | Filed Jul 29, 2026 | $39 | | SEC Form D |
| Accipiter Biosciences Inc. (funding history) | | Filed Jul 28, 2026 | $10.5M | | SEC Form D |
| Biosceptre International Ltd | | Filed Jul 28, 2026 | $345,981 | | SEC Form D |
| MiNDERA Corp (funding history) | | Filed Jul 28, 2026 | $30.4M | | SEC Form D |
| Pharmazz, Inc. (funding history) | | Filed Jul 28, 2026 | $250,000 | | SEC Form D |
| Sonavex, Inc. (funding history) | | Filed Jul 28, 2026 | $3.1M | | SEC Form D |
| Blue Arbor Technologies, Inc. (funding history) | | Filed Jul 27, 2026 | $10.2M | | SEC Form D |
| Estrigenix Therapeutics, Inc. | | Filed Jul 27, 2026 | $1M | | SEC Form D |
| Simbryo Technologies, Inc. | | Filed Jul 27, 2026 | $5.3M | | SEC Form D |
| Angelis Oncology, Inc. | | Filed Jul 23, 2026 | $400,000 | | SEC Form D |
| Cue Biopharma, Inc. (funding history) | | Filed Jul 22, 2026 | $50M | | SEC Form D |
| Holobiome, Inc. (funding history) | | Filed Jul 22, 2026 | $10M | | SEC Form D |
| Oncotelic Therapeutics, Inc. (funding history) | | Filed Jul 22, 2026 | $711,840 | | SEC Form D |
| TYBR Health, Inc. (funding history) | | Filed Jul 22, 2026 | $14.4M | | SEC Form D |
| ALZpath, Inc. | | Filed Jul 21, 2026 | $8.4M | | SEC Form D |
| CollPlant Biotechnologies Ltd (funding history) | | Filed Jul 20, 2026 | $10.4M | | SEC Form D |
| AB Science S.A. (funding history) | | Filed Jul 17, 2026 | $2M | | SEC Form D |
| Principal Technologies Inc. (funding history) | | Filed Jul 17, 2026 | $91,900 | | SEC Form D |
| AdvanCell, Inc. | | Filed Jul 16, 2026 | $218M | | SEC Form D |
| CellTrack Corp | | Filed Jul 16, 2026 | $30,000 | | SEC Form D |
| Sinopia Biosciences, Inc. | | Filed Jul 16, 2026 | $2.8M | | SEC Form D |
| Cadrenal Therapeutics, Inc. (funding history) | | Filed Jul 15, 2026 | $8.8M | | SEC Form D |
| Cambrian BioPharma Inc (funding history) | | Filed Jul 15, 2026 | $124M | | SEC Form D |
| GridAI Technologies Corp. (funding history) | | Filed Jul 15, 2026 | $8.5M | | SEC Form D |
| Headlands Holdco, LLC | | Filed Jul 15, 2026 | $3.1M | | SEC Form D |
| SelSym Biotech, Inc. | | Filed Jul 15, 2026 | $500,000 | | SEC Form D |
| ImmunoVec, Inc. | | Filed Jul 14, 2026 | $12.7M | | SEC Form D |
| Neurofold Therapeutics Inc. | | Filed Jul 14, 2026 | $6.5M | | SEC Form D |
| Sailie Bio, Inc. | | Filed Jul 14, 2026 | $100,000 | | SEC Form D |
| Silo Pharma, Inc. (funding history) | | Filed Jul 14, 2026 | $4M | | SEC Form D |
| Pluristyx Inc. | | Filed Jul 13, 2026 | $9.8M | | SEC Form D |
| Akadeum Life Sciences, Inc. (funding history) | | Filed Jul 9, 2026 | $2.1M | | SEC Form D |
| Amlogenyx Inc. (funding history) | | Filed Jul 9, 2026 | $10M | | SEC Form D |
| CeleCor Therapeutics, Inc. (funding history) | | Filed Jul 9, 2026 | $11.9M | | SEC Form D |
| Skybound Medtech Inc. | | Filed Jul 9, 2026 | $1.3M | | SEC Form D |
| MicroPure Genomics, Inc. | | Filed Jul 8, 2026 | $675,000 | | SEC Form D |
| Medicenna Therapeutics Corp. (funding history) | | Filed Jul 6, 2026 | $253,458 | | SEC Form D |
| Cognos Therapeutics Inc | | Filed Jul 2, 2026 | $250,000 | | SEC Form D |
| CYduct Diagnostics, Inc. | | Filed Jul 2, 2026 | $2M | | SEC Form D |
| HOPE-Neuron Therapeutx, Inc. | | Filed Jul 2, 2026 | $150,000 | | SEC Form D |
| Myrtelle Inc. (funding history) | | Filed Jul 2, 2026 | $16.7M | | SEC Form D |
| Andros Medicines Inc. | | Filed Jul 1, 2026 | $3M | | SEC Form D |
| Aquabounty Technologies Inc (funding history) | | Filed Jul 1, 2026 | $2.3M | | SEC Form D |
| Jaguar Health, Inc. (funding history) | | Filed Jul 1, 2026 | $2M | | SEC Form D |
| Pneuma Respiratory, Inc. (funding history) | | Filed Jul 1, 2026 | $3.6M | | SEC Form D |
| Promptus LLC (funding history) | | Filed Jul 1, 2026 | $100,000 | | SEC Form D |
| Andon Bio Inc. | | Filed Jun 30, 2026 | $250,000 | | SEC Form D |
| SonoThera, Inc. (funding history) | | Filed Jun 30, 2026 | $125M | | SEC Form D |
| Edesa Biotech, Inc. (funding history) | | Filed Jun 26, 2026 | $3.5M | | SEC Form D |
| Rapalogix Health, Inc. (funding history) | | Filed Jun 26, 2026 | $19.1M | | SEC Form D |
| Chickadee Biomedicines, Inc. | | Filed Jun 25, 2026 | $150,000 | | SEC Form D |
| Exactics, Inc. | | Filed Jun 25, 2026 | $855,000 | | SEC Form D |
| IceCure Medical Ltd. (funding history) | | Filed Jun 25, 2026 | $16.5M | | SEC Form D |
| Lycia Therapeutics, Inc. (funding history) | | Filed Jun 25, 2026 | $75M | | SEC Form D |
| Neonc Technologies Holdings, Inc. (funding history) | | Filed Jun 25, 2026 | $5M | | SEC Form D |
| Regentis Biomaterials Ltd. | | Filed Jun 25, 2026 | $6.5M | | SEC Form D |
| Sweet Chemistry, Inc. | | Filed Jun 25, 2026 | $1.6M | | SEC Form D |
| Boston Interactome, Inc. | | Filed Jun 24, 2026 | $500,000 | | SEC Form D |
| Ollin Biosciences, Inc. | | Filed Jun 24, 2026 | $156M | | SEC Form D |
| TETmedical, Inc. (funding history) | | Filed Jun 24, 2026 | $3.5M | | SEC Form D |
| Yutidetx Inc. | | Filed Jun 24, 2026 | $375,000 | | SEC Form D |
| Petragen, Inc. | | Filed Jun 23, 2026 | $495,000 | | SEC Form D |
| Tempest Therapeutics, Inc. (funding history) | | Filed Jun 23, 2026 | $4.1M | | SEC Form D |
| Aspira Women's Health Inc. (funding history) | | Filed Jun 22, 2026 | $1.5M | | SEC Form D |
| Balsam Pharmaceuticals Co | | Filed Jun 22, 2026 | $200,000 | | SEC Form D |
| Cellanome, Inc. (funding history) | | Filed Jun 22, 2026 | $75.9M | | SEC Form D |
| Dinya Dna, Inc. | | Filed Jun 22, 2026 | $3.8M | | SEC Form D |
| Nanomind, Inc. | | Filed Jun 22, 2026 | $2M | | SEC Form D |
| Nuclein, LLC (funding history) | | Filed Jun 22, 2026 | $1.3M | | SEC Form D |
| 5D Patient Journey, Inc. (funding history) | | Filed Jun 18, 2026 | $5.5M | | SEC Form D |
| Emblok, Inc. | | Filed Jun 18, 2026 | $6M | | SEC Form D |
| Liminatus Pharma, Inc. | | Filed Jun 18, 2026 | $1.9M | | SEC Form D |
| Rejuvenate Bio Inc | | Filed Jun 18, 2026 | $19.5M | | SEC Form D |
| Tolerance Bio Inc. | | Filed Jun 18, 2026 | $15.1M | | SEC Form D |
| Parley Neurotech Inc | | Filed Jun 17, 2026 | $140,000 | | SEC Form D |
| Pierogi Therapeutics, Inc | | Filed Jun 17, 2026 | $50,000 | | SEC Form D |
| Qlaris Bio, Inc. (funding history) | | Filed Jun 17, 2026 | $3.9M | | SEC Form D |
| Reservoir Neuroscience, Inc. (funding history) | | Filed Jun 17, 2026 | $3M | | SEC Form D |
| CND Life Sciences, Inc. (funding history) | | Filed Jun 16, 2026 | $4.3M | | SEC Form D |
| Memento Medicines, Inc. | | Filed Jun 16, 2026 | $38M | | SEC Form D |
| Peptaris, Inc. | | Filed Jun 16, 2026 | $4M | | SEC Form D |
| Immunis, Inc. (funding history) | | Filed Jun 15, 2026 | $12M | | SEC Form D |
| Nirrin Technologies, Inc. (funding history) | | Filed Jun 15, 2026 | $6.7M | | SEC Form D |
| Commense Bio, Inc. | | Filed Jun 12, 2026 | $2.5M | | SEC Form D |
| Eos SENOLYTIX, Inc. (funding history) | | Filed Jun 12, 2026 | $750,000 | | SEC Form D |
| Anodyne Nanotech, Inc. | | Filed Jun 11, 2026 | $12.6M | | SEC Form D |
| Duke Street Bio Ltd (funding history) | | Filed Jun 11, 2026 | $4.1M | | SEC Form D |
| Quince Therapeutics, Inc. (funding history) | | Filed Jun 11, 2026 | $115M | | SEC Form D |
| Barricade Therapeutics Corp | | Filed Jun 10, 2026 | $100,000 | | SEC Form D |
| Contraline, Inc. | | Filed Jun 10, 2026 | $55.8M | | SEC Form D |
| Haku Bio, Inc. (funding history) | | Filed Jun 10, 2026 | $1.3M | | SEC Form D |
| Ovelle Bio Corp. | | Filed Jun 10, 2026 | $7M | | SEC Form D |
| Thiogenesis Therapeutics, Corp. (funding history) | | Filed Jun 9, 2026 | $28,964 | | SEC Form D |
| Los Angeles Project Inc (funding history) | | Filed Jun 8, 2026 | $4.9M | | SEC Form D |
| Antlia Bioscience, Inc. | | Filed Jun 5, 2026 | $6M | | SEC Form D |
| Spine BioPharma, Inc. (funding history) | | Filed Jun 5, 2026 | $384,798 | | SEC Form D |
| Illuminare Biotechnologies Inc | | Filed Jun 4, 2026 | $3.6M | | SEC Form D |
| Senti Biosciences Holdings, Inc. (funding history) | | Filed Jun 4, 2026 | $10M | | SEC Form D |
| Ardego Therapeutics, Inc. | | Filed Jun 3, 2026 | $50,000 | | SEC Form D |
| Biolexis Therapeutics Inc. (funding history) | | Filed Jun 3, 2026 | $1.6M | | SEC Form D |
| BioStem Technologies, Inc. (funding history) | | Filed Jun 3, 2026 | $2.5M | | SEC Form D |
| Entact Bio, Inc. (funding history) | | Filed Jun 3, 2026 | $10M | | SEC Form D |
| Galaxy Diagnostics, Inc. (funding history) | | Filed Jun 3, 2026 | $3M | | SEC Form D |
| Goldenrod Therapeutics, Inc. | | Filed Jun 3, 2026 | $3.2M | | SEC Form D |
| Human Biotech, Inc. | | Filed Jun 3, 2026 | $10M | | SEC Form D |
| Optimeos Life Sciences, Inc. (funding history) | | Filed Jun 3, 2026 | $1M | | SEC Form D |
| Uniform Bio Inc. | | Filed Jun 2, 2026 | $1.7M | | SEC Form D |
| Atlas Discovery | AI-native pharma company | Summer 2026 | | Y Combinator batch | Y Combinator listing |
| Frontier Computing | Frontier grows scalable biological brains as an ML training substrate | Summer 2026 | | Y Combinator batch | Y Combinator listing |
| Gamgee | Scalable Personalised Cancer Treatment | Summer 2026 | | Y Combinator batch | Y Combinator listing |
| Gutgutgoose | We sequence your gut and build the probiotics it’s missing | Summer 2026 | | Y Combinator batch | Y Combinator listing |
| Illume Labs | 24/7 Personal Health & Longevity Companion | Summer 2026 | | Y Combinator batch | Y Combinator listing |
| Matthias Therapeutics, LLC (funding history) | | Filed Jun 1, 2026 | $50,000 | | SEC Form D |
| Neuromorphic | Building robots to automate wetlabs | Summer 2026 | | Y Combinator batch | Y Combinator listing |
| Omanta | A research lab for one | Summer 2026 | | Y Combinator batch | Y Combinator listing |
| Osseus | | Summer 2026 | | Y Combinator batch | Y Combinator listing |
| Rasyn | Making chemicals 100,000x faster | Summer 2026 | | Y Combinator batch | Y Combinator listing |
| RonanRx Inc. | Full Stack Pharmaceutical Company for Personalized Peptides and GLP-1s | Summer 2026 | | Y Combinator batch | Y Combinator listing |
| Spectre Intelligence | We are a multi-strategy trading firm that trains AI traders | Summer 2026 | | Y Combinator batch | Y Combinator listing |
| TareBio | Vaccines for any cancer or infection in weeks. | Summer 2026 | | Y Combinator batch | Y Combinator listing |
| WonderTx | Extrapolative AI to unlock First-in-Class drugs | Summer 2026 | | Y Combinator batch | Y Combinator listing |
| Imaginostics, Inc. (funding history) | | Filed May 29, 2026 | $40,000 | | SEC Form D |
| Portal Biotechnologies, Inc. (funding history) | | Filed May 29, 2026 | $9M | | SEC Form D |
| Potrero Medical, Inc. (funding history) | | Filed May 29, 2026 | $6.5M | | SEC Form D |
| Restora Medical, Inc. (funding history) | | Filed May 29, 2026 | $11.5M | | SEC Form D |
| StromaGenesis LLC | | Filed May 28, 2026 | $175,000 | | SEC Form D |
| Kayak Therapeutics, Inc. (funding history) | | Filed May 27, 2026 | $11.9M | | SEC Form D |
| Vivamed, Inc. (funding history) | | Filed May 27, 2026 | $3M | | SEC Form D |
| Oncosynergy, Inc. | | Filed May 26, 2026 | $6.6M | | SEC Form D |
| Reprogram Biosciences, Inc. (funding history) | | Filed May 26, 2026 | $5M | | SEC Form D |
| TenNor Therapeutics (Suzhou) Ltd | | Filed May 26, 2026 | $14.7M | | SEC Form D |
| Novascan Inc. (funding history) | | Filed May 22, 2026 | $671,492 | | SEC Form D |
| beyondGREEN biotech Inc. (funding history) | | Filed May 21, 2026 | $300,000 | | SEC Form D |
| Reprise Biomedical, Inc. (funding history) | | Filed May 21, 2026 | $1.4M | | SEC Form D |
| ViCardia Therapeutics, Inc. | | Filed May 21, 2026 | $700,000 | | SEC Form D |
| Ropana Vascular Inc. | | Filed May 20, 2026 | $100,000 | | SEC Form D |
| Verismo Therapeutics, Inc. (funding history) | | Filed May 20, 2026 | $28M | | SEC Form D |
| CNS Pharmaceuticals, Inc. | | Filed May 19, 2026 | $22.5M | | SEC Form D |
| ReelReactor, Inc. (funding history) | | Filed May 18, 2026 | $500,000 | | SEC Form D |
| Remedium Bio Inc. (funding history) | | Filed May 18, 2026 | $1.5M | | SEC Form D |
| Athos Therapeutics, Inc. (funding history) | | Filed May 15, 2026 | $10.3M | | SEC Form D |
| Auxilium Health, Inc. | | Filed May 15, 2026 | $3M | | SEC Form D |
| Majesty Therapeutics, Inc. | | Filed May 15, 2026 | $100,000 | | SEC Form D |
| Trellis Bioscience, Inc. | | Filed May 15, 2026 | $6.1M | | SEC Form D |
| Veradermics, Inc (funding history) | | Filed May 15, 2026 | $30M | | SEC Form D |
